Home » Topics » BioWorld Science

BioWorld Science
RSS

Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy

June 11, 2021

Vor Biopharma and Abound Bio partner to develop multi-targeted CAR-Ts

June 11, 2021

Berdazimer sodium shows promising efficacy in preclinical SARS-CoV-2 transmission model

June 11, 2021

Sovateltide slows down the progression of Alzheimer's disease in phase II study

June 11, 2021

First patient dosed in phase I study of CID-103 in multiple myeloma

June 11, 2021

China's NMPA approves clinical trial application for sirolimus for injection (albumin-bound)

June 11, 2021

Targovax presents 24-month data from phase I/II study of ONCOS-102 in mesothelioma

June 11, 2021

Penpulimab is highly active in relapsed/refractory classical Hodgkin's lymphoma

June 11, 2021

New HBV HBsAg secretion inhibitors synthesized at Arbutus Biopharma

June 11, 2021

Zhejiang Hisun Pharmaceutical divulges new RET and/or VEGFR-2 inhibitors

June 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...